Curated News
By: NewsRamp Editorial Staff
October 15, 2026
AI Maverick Intel to Acquire Heal Access in $5M Deal
TLDR
- AIMV acquires Heal Access Canada for $5 million, gaining an AI platform serving 118,000 patients across five countries.
- AIMV's acquisition involves a $5 million promissory note at 10% interest and 20 million exchangeable shares, pending $6 million financing.
- Heal Access uses AI to integrate patient data and support clinical workflows, improving healthcare delivery for over 118,000 patients worldwide.
- AIMV corrected its September announcement, clarifying the binding agreement was signed on October 12, 2026, not September 21.
Impact - Why it Matters
This acquisition signals a significant consolidation in the AI healthcare space, with AI Maverick Intel positioning itself to leverage Heal Access's proven platform that already serves over 118,000 patients across five countries. For investors, the deal highlights the growing importance of agentic AI in healthcare workflows, potentially unlocking new efficiencies and revenue streams. The financing condition and HEAL Group's increased stake also underscore the strategic commitment of the controlling stockholder, which could drive further acquisitions and growth. As AI continues to transform healthcare, this move could set a precedent for similar roll-ups, impacting how patient data is integrated and care is delivered globally.
Summary
AI Maverick Intel (OTCID: AIMV) has announced a definitive share purchase agreement to acquire Heal Access Canada Inc., an artificial intelligence healthcare technology company, from its controlling stockholder, HEAL Group Holdings Inc. The deal includes $5 million in consideration via a secured, two-year promissory note bearing 10% annual interest, plus 20 million exchangeable shares convertible into AIMV common stock. Heal Access operates an AI-powered healthcare intelligence platform that integrates patient information and supports clinical workflows. The platform is operational in five countries and serves more than 118,000 patients. The acquisition is subject to closing conditions, including at least $6 million in financing and independent special committee ratification.
AIMV expects to use commercially reasonable efforts to complete the required financing by Dec. 31, 2026, with either party permitted to terminate the agreement if the transaction has not closed by Feb. 28, 2027. The company will also assume approximately $6.4 million in existing obligations owed by Heal Access and its subsidiaries to HEAL Group and affiliates. AIMV clarified that its Sept. 21 announcement incorrectly described the acquisition agreement as definitive, noting that the binding agreement was signed Oct. 12, 2026. Upon conversion of all exchangeable shares, HEAL Group would hold approximately 80.1% of AIMV common stock before accounting for any shares issued in the financing.
To view the full press release, visit https://ibn.fm/1XVOv. TechMediaWire (TMW) is a specialized communications platform focused on pioneering public and private companies driving the future of technology. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution via IBN, and tailored corporate communications solutions.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, AI Maverick Intel to Acquire Heal Access in $5M Deal
